Grants which include Medical Educational Goods and Services (MEGS).
Novartis Pharmaceuticals UK (Novartis) Limited may provide grant support on request to healthcare organisations and patient groups in the form of financial support (monetary grants), and to healthcare organisations in the form of medical educational goods and services (MEGS).
Requests for Financial Grants
Novartis can provide reasonable financial support for the general purpose of supporting healthcare initiatives like: improving medical infrastructure, independent educational activities, support for healthcare professional societies, health and medical policy research, and patient group activities. If you are interested in obtaining financial support from Novartis and are a healthcare organisation or professional society, please complete the 'Healthcare Organisation Request for Financial Information' (145KB) application form. If you are a patient group please complete the 'Patient Group Request for Financial Support' (149KB) application form. The application forms can be found below.
Educational grants will be considered which support the organisation of meetings where the content of the programme is wholly controlled by an independent organisation and Novartis has no input or influence over the content. If a grant is awarded, this support must be acknowledged on any documentation advertising the event.
A key principle of Novartis’ grant policy is that Novartis does not support requests which benefit individuals, including requests for personal ongoing education and requests for travel grants to attend an educational meeting.
Requests for MEGS Support
Novartis has a number of medical educational goods and services (MEGS) which are available on request. For further information on MEGS please refer to Clause 19 of the ABPI Code of Practice.
Listed below are types of Novartis MEGS which we can provide to healthcare organisations to benefit patients and support the NHS. If you are interested in applying for Novartis MEGS, please complete the 'Novartis MEGS Request Form' (97KB) below indicating which of our MEGS you are interested in and to request a meeting with a Novartis medical associate to discuss your request further.
1. Nursing support for patient review services 2. Service audits to facilitate service and patient pathways redesign 3. Nursing support for patient database audit review 4. Support for research activities
Not all of the above types of MEGS are available for all disease areas. If you would like to submit a request for your own bespoke MEGS proposal, please indicate this on the 'Novartis MEGS Request Form' (97KB) including both your contact details and attach a detailed description of your proposal with a request for a meeting with a Novartis medical associate to discuss your proposal further.
In 2020, Novartis is also able to offer a limited number of non-promotional training and capability development programmes available for healthcare teams who meet the eligibility criteria via our Advance+ programme. The programmes are Novartis funded and the transfer of value will be publicly disclosed.
The programme offers modular courses with workshops tailored to the needs of your local team. 2 courses are available: business skills for the NHS and understanding the NHS.
If you are interested in applying for an Advance+ MEGS programme please complete the Advance+ MEGS request form here.
For more information please email [email protected] or contact your local Patient Access Manager.
Healthcare organisations, professional societies and sometimes patient support groups may wish to approach Novartis for sponsorship e.g. asking Novartis to pay to sponsor a meeting for which Novartis will receive tangible benefits e.g. stand space, a number of places to attend the conference, a mention in the meeting brochure etc.
Novartis is pleased to consider such requests and healthcare organisations and professional societies should approach either their sales, marketing or medical contact. Any request from patient support groups should be directed to the Head Office Patient Advocacy Team. If an organisation does not currently have a contact within Novartis, please telephone our main switchboard (01276 692255) and you will be directed to someone appropriate.
For all forms of grant requests and sponsorships, provision is subject to: (i) available capacity; (ii) the request meeting the criteria for the available support; and (iii) provision being permitted within applicable laws, guidelines and codes (for example the ABPI Code of Practice). Unfortunately, Novartis is unable to meet all of the requests it receives. We will prioritise those requests which are aligned to our therapy areas and focus on supporting both scientific and charitable organisations which directly support patients, improve healthcare and enable ongoing education.
Disclosure of Payments
All grant support to patient groups is published annually on the Novartis website.
Grant and MEGS Application Process
Requests should be submitted a minimum of three months prior to the activity or event. Each request will be evaluated on its merits and the value it brings to patient care and benefit to the NHS.
Please note that it is important to fill out all the sections on the form with the information required as failure to do so could result in either a rejection or a request for additional information which will delay your application.
If you have any supporting documentation you consider relevant to the application you can attach this to your email. Please note that for legibility reasons we will only accept forms that have been completed electronically. Applications may also be typed and posted to UK GRANTS at Novartis Pharmaceuticals UK Ltd, 2nd Floor, The WestWorks Building, White City Place, 195 Wood Lane, London, W12 7FQ.
The personal information you submit in your application will be used by Novartis only for the purposes of processing the grant application, and any associated disclosure. Any and all uses will comply with all applicable laws.
All requests are monitored for reporting adverse events. You agree to be contacted should your completed application form contain information relevant to our adverse event reporting commitments.
All requests are reviewed by an independent review panel and results will be communicated after the review panel has met. Funding can only be paid to reputable organisations and checks on organisations to confirm this will be made.